Search Results - "Cenderello, G"

Randomised clinical trial: sofosbuvir and ledipasvir in patients with transfusion‐dependent thalassaemia and HCV genotype 1 or 4 infection by Mangia, A., Sarli, R., Gamberini, R., Piga, A., Cenderello, G., Piazzolla, V., Santoro, R., Caruso, V., Quarta, A., Ganga, R., Copetti, M., Forni, G.

“…Summary Background Patients with thalassaemia major depend on blood transfusions. In Italy, up to 80% of thalassaemia patients bear HCV antibodies due to HCV…”
Get full text

Resistance analysis and treatment outcomes in hepatitis C virus genotype 3‐infected patients within the Italian network VIRONET‐C by Di Maio, Velia Chiara, Barbaliscia, Silvia, Teti, Elisabetta, Fiorentino, Gianluca, Milana, Martina, Paolucci, Stefania, Pollicino, Teresa, Morsica, Giulia, Starace, Mario, Bruzzone, Bianca, Gennari, William, Micheli, Valeria, Yu La Rosa, Katia, Foroghi, Luca, Calvaruso, Vincenza, Lenci, Ilaria, Polilli, Ennio, Babudieri, Sergio, Aghemo, Alessio, Raimondo, Giovanni, Sarmati, Loredana, Coppola, Nicola, Pasquazzi, Caterina, Baldanti, Fausto, Parruti, Giustino, Perno, Carlo Federico, Angelico, Mario, Craxì, Antonio, Andreoni, Massimo, Ceccherini‐Silberstein, Francesca, Andreone, P, Aragri, M, Bertoli, A, Boeri, E, Brancaccio, G, Brunetto, M, Callegaro, AP, Cenderello, G, Cento, V, Ciaccio, A, Ciancio, A, Cuomo, N, De Santis, A, Di Biagio, A, Di Marco, V, Di Perri, G, Di Stefano, MA, Gaeta, GB, Ghisetti, V, Gulminetti, R, Lampertico, P, Landonio, S, Lichtner, M, Lleo, A, Maida, I, Marenco, S, Masetti, C, Mastroianni, C, Minichini, C, Milano, E, Monno, L, Novati, S, Pace Palitti, V, Paternoster, C, Pellicelli, A, Pieri, A, Puoti, M, Rizzardini, G, Ruggiero, T, Rossetti, B, Sangiovanni, V, Santantonio, T, Taliani, G, Toniutto, P, Vullo, V., Zazzi, M

“…Aim This study aimed to investigate the role of resistance‐associated substitutions (RASs) to direct‐acting‐antivirals (DAAs) in HCV genotype 3 (GT3). Methods…”
Get full text

An unexpected waterborne traveller by Riccardi, N., Cenderello, G., Costa, M., Cassola, G.

Get full text

Bloodstream infections in patients living with HIV in the modern cART era by Taramasso, L., Liggieri, F., Cenderello, G., Bovis, F., Giannini, B., Mesini, A., Giacomini, M., Cassola, G., Viscoli, C., Di Biagio, A.

“…Retrospective multicentre study aiming at analysing the etiology, characteristics and outcome of bloodstream infections (BSI) in people living with HIV…”
Get full text

Quality of life in an Italian cohort of people living with HIV in the era of combined antiretroviral therapy (Evidence from I.A.N.U.A. study-investigation on antiretroviral therapy) by Venturini, A., Cenderello, G., Di Biagio, A., Giannini, B., Ameri, M., Giacomini, M., Montefiori, M., Setti, M., Mazzarello, G., Merlano, C., Orcamo, P., Viscoli, C., Cassola, G.

“…The aims of this study were to assess the Health Related Quality of Life (HRQoL) of People Living with HIV/AIDS (PLWHA) who attend outpatient services in…”
Get full text

Current treatment options for hepatitis C virus/human immunodeficiency virus patients: the experience of the scolta project by Menzaghi, B, Ricci, E, Magni, C, Parruti, G, Nicolini, L, Cenderello, G, Peruzzu, F, Gussio, M, Gulminetti, R, Bonfanti, P

Get full text

Predictors of sustained virological response 12 weeks after the end of treatment in hepatitis C virus GT3 infected patients receiving IFN-free antiviral treatments by Mangia, A, Santoro, R, Cenderello, G, Piazzolla, V, Petruzzellis, D, Potenza, D, Squillante, M.M, Cela, M, De Stefano, G

Get full text

Survival in HIV‐infected patients with lymphoma according to the choice of antiretroviral treatment: an observational multicentre study by Focà, E, Cavaglià, G, Rusconi, S, Cascavilla, A, Cenderello, G, Re, A, Casari, S, Bogaart, L, Zinzani, PL, Caracciolo, D, Di Perri, G, Bonito, A, Lucchini, A, Cassola, G, Viale, P, Calcagno, A

“…Objectives Lymphoproliferative disorders are often observed in HIV‐positive patients. Combination antiretroviral treatment (cART) during antineoplastic…”
Get full text

Effect of hepatitis B virus on steatosis in hepatitis C virus co‐infected subjects: A multi‐centre study and systematic review by Goossens, N., Vito, C., Mangia, A., Clément, S., Cenderello, G., Barrera, F., D'Ambrosio, R., Coppola, N., Zampino, R., Stanzione, M., Adinolfi, L. E., Wedemeyer, H., Semmo, N., Müllhaupt, B., Semela, D., Malinverni, R., Moradpour, D., Heim, M., Trincucci, G., Rubbia‐Brandt, L., Negro, F., Piazzolla, Valeria, Santoro, Rosanna, Dufour, Jean‐Francois, Brunner, Barbara, Weber, Achim, Herranz, Maribelle, Mathieu, Adeline, Clerc, Olivier, Elisabetta, Degasperi, Floriana, Facchetti, Macera, Margherita, Pisaturo, Mariantonietta, Stornaiuolo, Gianfranca, Rinaldi, Luca, George, Jacob, Mix, Carola, Cornberg, Markus

“…Summary It remains unclear whether hepatitis B virus (HBV) infection may modify the severity of viral steatosis in patients coinfected with chronic hepatitis C…”
Get full text

Raltegravir Plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-Positive Patients: Safety, Efficacy and Pharmacokinetics by Calcagno, Andrea, Montrucchio, Chiara, Capetti, Amedeo, Guaraldi, G, Cenderello, G, Calza, Leonardo, Lanzafame, M, Marinaro, Letizia, Tettoni, M C, Trentini, Laura, D'Avolio, Aantonio, Di Perri, Giovanni, Bonora, Stefano

“…Tolerability, long-term toxicities and selection of resistant variants limit the use and efficacy of antiretroviral drugs in HIV-positive patients. Novel…”
Get more information

Effectiveness, safety, durability and immune recovery in a retrospective, multicentre, observational cohort of ART-experienced, HIV-1-infected patients receiving maraviroc by Dentone, C, Sterrantino, G, Signori, A, Cenderello, G, Guerra, M, De Leo, P, Bartolacci, V, Mantia, E, Orofino, G, Giacomini, M, Bruzzone, B, Francisci, D, Di Biagio, A

“…The aim of this retrospective, multicentre, observational study was to assess the durability, safety, immune recovery and effectiveness on viral suppression of…”
Get more information

Could anti-HCV treatment prevent recurrence of hepatocellular carcinoma in HIV-infected patients? Two case reports by Cenderello, G., Pontali, E., Cassola, G., Torresin, A.

“…Highly active antiretroviral therapy (HAART) has proven long-term efficacy in human immunodeficiency virus (HIV) infection. Combination therapy with pegylated…”
Get full text

P.17.11 HIGH RATES OF VIROLOGICAL RESPONSES WITH PEG-IFN AND RBV RE-TREATMENT FOLLOWING RELAPSE TO SOF+RBV by Mangia, A, Cenderello, G, Matera, G, Santoro, R, Ripoli, M, Mottola, L, Piazzolla, V

Get full text

Predictors of Costs of Antiretrovirals for HIV Infection in Italy: A Multicentric Retrospection in 2012 by Tontodonati, M, Cenderello, G, Celesia, B.M, Trezzi, M, Ursini, T, Costantini, A, Gaggero, D, Gussio, M, Manzoli, L, Polilli, E, Sozio, F, Catalani, C, Butini, L, Parruti, G

Get full text

Conserved T cell and natural killer cell function in treatment-experienced adults receiving tenofovir plus didanosine as nucleoside reverse transcription inhibitor backbone by Costa, P, Bozzano, F, Fenoglio, D, Beltrame, A, Cenderello, G, Di Biagio, A, Ferrea, G, Pagano, G, De Maria, A

“…Anti-retroviral treatment (ART) usually results in efficient control of virus replication and in immune reconstitution. Among potential adverse effects,…”
Get full text

Linezolid Treatment of Prosthetic Hip Infections due to Methicillin-resistant Staphylococcus aureus (MRSA) by Bassetti, M., Di Biagio, A., Cenderello, G., Del Bono, V., Palermo, A., Cruciani, M., Bassetti, D.

“…Prosthetic joint infection is an infrequent but serious complication of total joint arthroplasty. Complete removal of all foreign material is essential,…”
Get full text

Impact of an antimicrobial formulary and restriction policy in the largest hospital in Italy by Bassetti, M., Di Biagio, A., Rebesco, B., Cenderello, G., Amalfitano, M.E., Bassetti, D.

“…We have analysed the expenditure on antimicrobial drugs in the largest hospital in Italy; over this period, a committee prepared an antibiotic policy document…”
Get full text

Gram-positive bacterial resistance. A challenge for the next millennium by Bassetti, M, Melica, G, Cenderello, G, Rosso, R, Di Biagio, A, Bassetti, D

“…Penicillin G was first used in 1941. Since then, the trend in bacterial infections has changed. New antibiotics have been developed and bacterial resistance…”
Get more information

PIN112 - HEALTH TECHNOLOGY ASSESSMENT OF THE AVAILABLE NRTI BACKBONES IN ITALY by Garagiola, E., Foglia, E., Ferrario, L., Cenderello, G., Di biagio, A., Menzaghi, B., Rizzardini, G., Croce, D.

Get full text

THU-211 - Predictors of sustained virological response 12 weeks after the end of treatment in hepatitis C virus GT3 infected patients receiving IFN-free antiviral treatments by Mangia, A., Santoro, R., Cenderello, G., Piazzolla, V., Petruzzellis, D., Potenza, D., Squillante, M.M., Cela, M., De Stefano, G.

Get full text